AMEUF OTC Stock Buy Hold or Sell Recommendation

AMEUF -  USA Stock  

USD 6.29  0.28  4.66%

Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Admedus is 'Strong Sell'. Macroaxis provides Admedus buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Admedus positions. The advice algorithm takes into account all of Admedus' available fundamental, technical, and predictive indicators you will find on this site.

Search Advice 

The advice is provided from Admedus' buy-and-hold perspective. Please continue to Admedus Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as AMEUF and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Admedus.

Execute Admedus Buy or Sell Advice

The AMEUF recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Admedus. Macroaxis does not own or have any residual interests in Admedus or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Admedus' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell AdmedusBuy Admedus
Strong Sell


Moderately volatileDetails

Hype Condition


Current Valuation

Fairly ValuedDetails

Odds of Distress

Below AverageDetails

Economic Sensitivity

Barely shadows the marketDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

For the selected time horizon Admedus has a Mean Deviation of 2.03, Standard Deviation of 4.32 and Variance of 18.67
We provide trade advice to complement the prevailing expert consensus on Admedus. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Admedus is not overpriced, please confirm all Admedus fundamentals, including its cash per share, beta, and the relationship between the gross profit and book value per share . Given that Admedus has a price to earning of (3.20) X, we suggest you to validate Admedus market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Admedus Trading Alerts and Improvement Suggestions

Admedus generates negative expected return over the last 90 days
Admedus has high historical volatility and very poor performance
The company reported the revenue of 7.08 M. Net Loss for the year was (15.27 M) with profit before overhead, payroll, taxes, and interest of 4.36 M.
Admedus has accumulated about 4.35 M in cash with (14.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.7.
Roughly 18.0% of the company shares are held by company insiders
Latest headline from Vascular Patches Market 2021 Expanding Application Areas To Drive The Global Market Growth Renewable Energy Zone - Renewable Energy Zone

Admedus Returns Distribution Density

The chart of the probability distribution of Admedus stock daily returns describes the distribution of returns around its average expected value. We use Admedus' stock's Value At Risk and its Upside Potential as a relative measure of the distribution. The distribution of Admedus returns is essential to provide solid investment advice for Admedus stock.
Mean Return-0.47Value At Risk-9.24
Potential Upside4.66Standard Deviation4.32
 Return Density 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Admedus historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Admedus Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Admedus or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Admedus stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a AMEUF stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over DOW
Beta against DOW0.18
Overall volatility
Information ratio -0.12

Admedus Volatility Alert

Admedus exhibits very low volatility with skewness of -0.9 and kurtosis of 6.84. However, we advise investors to further study Admedus technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Admedus' otc stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Admedus' otc stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Admedus Fundamentals Vs Peers

Comparing Admedus' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Admedus' direct or indirect competition across all of the common fundamentals between Admedus and the related equities. This way, we can detect undervalued stocks with similar characteristics as Admedus or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Admedus' fundamental indicators could also be used in its relative valuation, which is a method of valuing Admedus by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare Admedus to competition

About Admedus Buy or Sell Advice

When is the right time to buy or sell Admedus? Buying stocks such as Admedus isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Admedus investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Admedus in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Technology Thematic Idea Now

Technology Theme
Companies that are involved in development or distribution of technologically based goods and services such as software, IT or electronics. Technology theme has 30 constituents.
View All  Next Launch Technology
Please continue to Admedus Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Admedus information on this page should be used as a complementary analysis to other Admedus' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Admedus OTC Stock analysis

When running Admedus price analysis, check to measure Admedus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Admedus is operating at the current time. Most of Admedus' value examination focuses on studying past and present price action to predict the probability of Admedus' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Admedus' price. Additionally, you may evaluate how the addition of Admedus to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
The market value of Admedus is measured differently than its book value, which is the value of AMEUF that is recorded on the company's balance sheet. Investors also form their own opinion of Admedus' value that differs from its market value or its book value, called intrinsic value, which is Admedus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Admedus' market value can be influenced by many factors that don't directly affect Admedus underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Admedus' value and its price as these two are different measures arrived at by different means. Investors typically determine Admedus value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Admedus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.